Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

2.4%

1 terminated/withdrawn out of 42 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

48%

20 trials in Phase 3/4

Results Transparency

7%

1 of 15 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
14(46.7%)
N/A
10(33.3%)
Phase 3
6(20.0%)
30Total
Phase 4(14)
N/A(10)
Phase 3(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials
NCT06736665Not ApplicableRecruiting

Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).

Role: lead

NCT05619601Completed

Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction

Role: lead

NCT05890716Recruiting

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

Role: collaborator

NCT05434962Not ApplicableActive Not Recruiting

The Left Bundle Cardiac Resynchronization Therapy Trial

Role: collaborator

NCT06887257Not ApplicableCompleted

RECOVER WITH INOCA: A Study of a Cardiac Rehabilitation Program in Patients With Ischemia With Nonobstructive Coronary Artery Disease (INOCA)

Role: collaborator

NCT04765943Active Not Recruiting

Prognosis Impact of NSVTs After an AMI (TeVeO Study).

Role: collaborator

NCT04696185Phase 4Completed

Dapagliflozin After Transcatheter Aortic Valve Implantation

Role: lead

NCT06755801Phase 3Not Yet Recruiting

Nebivolol ANOCA Treatment Randomized Trial

Role: lead

NCT06742970Not ApplicableNot Yet Recruiting

Telematic Intervention for Reversing Frailty Among Older Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Intervention. the TELE-FRAIL TAVI Clinical Trial

Role: lead

NCT06645249Phase 4Not Yet Recruiting

Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation

Role: collaborator

NCT06509074Phase 4Not Yet Recruiting

Beta-Blockers in Takotsubo Syndrome Study

Role: lead

NCT05689970Active Not Recruiting

ST-segment Elevation Not Associated With Acute Cardiac Necrosis (LESTONNAC)

Role: collaborator

NCT06049992Not ApplicableUnknown

STylet-driven vs. LumenlEss Lead in Left-Bundle-Branch Pacing

Role: collaborator

NCT05923138Not ApplicableUnknown

Nutritional Approach in Adults Followed up in Spanish Hospitals for Heart Failure (BOCADOS-IC)

Role: lead

NCT04533997Phase 3Completed

Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

Role: collaborator

NCT02548364Phase 3Completed

Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)

Role: collaborator

NCT04707352Phase 3Completed

Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure .

Role: collaborator

NCT05825339Unknown

Absolute Flow for Ischemia With No Obstructive Coronary Arteries

Role: lead

NCT03248557Completed

Prognostic Value of Ventricular Fibrillation Spectral Analysis in Sudden Cardiac Death

Role: collaborator

NCT03208153Not ApplicableCompleted

the Invasive and Conservative Strategies in Elderly Frail Patients With Non-STEMI

Role: collaborator